Enhancing Cardioprotection Through Neutrophil‐Mediated Delivery of 18β‐Glycyrrhetinic Acid in Myocardial Ischemia/Reperfusion Injury
Abstract Myocardial ischemia/reperfusion injury (MI/RI) generates reactive oxygen species (ROS) and initiates inflammatory responses. Traditional therapies targeting specific cytokines or ROS often prove inadequate. An innovative drug delivery system (DDS) is developed using neutrophil decoys (NDs)...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-11-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202406124 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850274092859523072 |
|---|---|
| author | Dongjian Han Fuhang Wang Qingjiao Jiang Zhentao Qiao Yuansong Zhuang Quanxu An Yuhang Li Yazhe Tang Chenyao Li Deliang Shen |
| author_facet | Dongjian Han Fuhang Wang Qingjiao Jiang Zhentao Qiao Yuansong Zhuang Quanxu An Yuhang Li Yazhe Tang Chenyao Li Deliang Shen |
| author_sort | Dongjian Han |
| collection | DOAJ |
| description | Abstract Myocardial ischemia/reperfusion injury (MI/RI) generates reactive oxygen species (ROS) and initiates inflammatory responses. Traditional therapies targeting specific cytokines or ROS often prove inadequate. An innovative drug delivery system (DDS) is developed using neutrophil decoys (NDs) that encapsulate 18β‐glycyrrhetinic acid (GA) within a hydrolyzable oxalate polymer (HOP) and neutrophil membrane vesicles (NMVs). These NDs are responsive to hydrogen peroxide (H2O2), enabling controlled GA release. Additionally, NDs adsorb inflammatory factors, thereby reducing inflammation. They exhibit enhanced adhesion to inflamed endothelial cells (ECs) and improved penetration. Once internalized by cardiomyocytes through clathrin‐mediated endocytosis, NDs protect against ROS‐induced damage and inhibit HMGB1 translocation. In vivo studies show that NDs preferentially accumulate in injured myocardium, reducing infarct size, mitigating adverse remodeling, and enhancing cardiac function, all while maintaining favorable biosafety profiles. This neutrophil‐based system offers a promising targeted therapy for MI/RI by addressing both inflammation and ROS, holding potential for future clinical applications. |
| format | Article |
| id | doaj-art-2e541b48be184aa4aa1224dddd4e0222 |
| institution | OA Journals |
| issn | 2198-3844 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Wiley |
| record_format | Article |
| series | Advanced Science |
| spelling | doaj-art-2e541b48be184aa4aa1224dddd4e02222025-08-20T01:51:14ZengWileyAdvanced Science2198-38442024-11-011142n/an/a10.1002/advs.202406124Enhancing Cardioprotection Through Neutrophil‐Mediated Delivery of 18β‐Glycyrrhetinic Acid in Myocardial Ischemia/Reperfusion InjuryDongjian Han0Fuhang Wang1Qingjiao Jiang2Zhentao Qiao3Yuansong Zhuang4Quanxu An5Yuhang Li6Yazhe Tang7Chenyao Li8Deliang Shen9Department of Cardiology The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 ChinaDepartment of Cardiology The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 ChinaDepartment of Cardiology The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 ChinaDepartment of Vascular and Endovascular Surgery The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 ChinaDepartment of Cardiology The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 ChinaDepartment of Cardiology The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 ChinaDepartment of Cardiology The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 ChinaDepartment of Cardiology The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 ChinaDepartment of Cardiology The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 ChinaDepartment of Cardiology The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 ChinaAbstract Myocardial ischemia/reperfusion injury (MI/RI) generates reactive oxygen species (ROS) and initiates inflammatory responses. Traditional therapies targeting specific cytokines or ROS often prove inadequate. An innovative drug delivery system (DDS) is developed using neutrophil decoys (NDs) that encapsulate 18β‐glycyrrhetinic acid (GA) within a hydrolyzable oxalate polymer (HOP) and neutrophil membrane vesicles (NMVs). These NDs are responsive to hydrogen peroxide (H2O2), enabling controlled GA release. Additionally, NDs adsorb inflammatory factors, thereby reducing inflammation. They exhibit enhanced adhesion to inflamed endothelial cells (ECs) and improved penetration. Once internalized by cardiomyocytes through clathrin‐mediated endocytosis, NDs protect against ROS‐induced damage and inhibit HMGB1 translocation. In vivo studies show that NDs preferentially accumulate in injured myocardium, reducing infarct size, mitigating adverse remodeling, and enhancing cardiac function, all while maintaining favorable biosafety profiles. This neutrophil‐based system offers a promising targeted therapy for MI/RI by addressing both inflammation and ROS, holding potential for future clinical applications.https://doi.org/10.1002/advs.202406124drug deliveryinflammationmyocardial ischemia‐reperfusion injurynanomedicineneutrophil decoys (NDs)reactive oxygen species (ROS) |
| spellingShingle | Dongjian Han Fuhang Wang Qingjiao Jiang Zhentao Qiao Yuansong Zhuang Quanxu An Yuhang Li Yazhe Tang Chenyao Li Deliang Shen Enhancing Cardioprotection Through Neutrophil‐Mediated Delivery of 18β‐Glycyrrhetinic Acid in Myocardial Ischemia/Reperfusion Injury Advanced Science drug delivery inflammation myocardial ischemia‐reperfusion injury nanomedicine neutrophil decoys (NDs) reactive oxygen species (ROS) |
| title | Enhancing Cardioprotection Through Neutrophil‐Mediated Delivery of 18β‐Glycyrrhetinic Acid in Myocardial Ischemia/Reperfusion Injury |
| title_full | Enhancing Cardioprotection Through Neutrophil‐Mediated Delivery of 18β‐Glycyrrhetinic Acid in Myocardial Ischemia/Reperfusion Injury |
| title_fullStr | Enhancing Cardioprotection Through Neutrophil‐Mediated Delivery of 18β‐Glycyrrhetinic Acid in Myocardial Ischemia/Reperfusion Injury |
| title_full_unstemmed | Enhancing Cardioprotection Through Neutrophil‐Mediated Delivery of 18β‐Glycyrrhetinic Acid in Myocardial Ischemia/Reperfusion Injury |
| title_short | Enhancing Cardioprotection Through Neutrophil‐Mediated Delivery of 18β‐Glycyrrhetinic Acid in Myocardial Ischemia/Reperfusion Injury |
| title_sort | enhancing cardioprotection through neutrophil mediated delivery of 18β glycyrrhetinic acid in myocardial ischemia reperfusion injury |
| topic | drug delivery inflammation myocardial ischemia‐reperfusion injury nanomedicine neutrophil decoys (NDs) reactive oxygen species (ROS) |
| url | https://doi.org/10.1002/advs.202406124 |
| work_keys_str_mv | AT dongjianhan enhancingcardioprotectionthroughneutrophilmediateddeliveryof18bglycyrrhetinicacidinmyocardialischemiareperfusioninjury AT fuhangwang enhancingcardioprotectionthroughneutrophilmediateddeliveryof18bglycyrrhetinicacidinmyocardialischemiareperfusioninjury AT qingjiaojiang enhancingcardioprotectionthroughneutrophilmediateddeliveryof18bglycyrrhetinicacidinmyocardialischemiareperfusioninjury AT zhentaoqiao enhancingcardioprotectionthroughneutrophilmediateddeliveryof18bglycyrrhetinicacidinmyocardialischemiareperfusioninjury AT yuansongzhuang enhancingcardioprotectionthroughneutrophilmediateddeliveryof18bglycyrrhetinicacidinmyocardialischemiareperfusioninjury AT quanxuan enhancingcardioprotectionthroughneutrophilmediateddeliveryof18bglycyrrhetinicacidinmyocardialischemiareperfusioninjury AT yuhangli enhancingcardioprotectionthroughneutrophilmediateddeliveryof18bglycyrrhetinicacidinmyocardialischemiareperfusioninjury AT yazhetang enhancingcardioprotectionthroughneutrophilmediateddeliveryof18bglycyrrhetinicacidinmyocardialischemiareperfusioninjury AT chenyaoli enhancingcardioprotectionthroughneutrophilmediateddeliveryof18bglycyrrhetinicacidinmyocardialischemiareperfusioninjury AT deliangshen enhancingcardioprotectionthroughneutrophilmediateddeliveryof18bglycyrrhetinicacidinmyocardialischemiareperfusioninjury |